Biotech company 23andMe had a rough 2024, including a $30 million settlement payment after customer data was compromised.

In a report released on January 9, David Evans from Kepler Capital maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a ...

GSK PLC GSK shares were unchanged Friday at £13.50, on what proved to be an all-around grim trading session for the stock ...

This week, the FDA granted priority review status to J&J’s JNJ application seeking approval of key pipeline candidate ...

Ouro Medicines, a biotechnology company developing immune reset therapeutics for people living with chronic immune-mediated diseases, today announced its launch with $120 million in funding. The ...

British drug maker GSK plc (GSK, GSK.L) announced Friday that the US Food and Drug Administration has accepted for review the ...

NEW YORK (PIX11) — A young man, homeless and disheveled, was surrounded by a joint response team made up of two NYPD officers ...

The FDA will require GSK and Pfizer to include on the label of their respiratory syncytial virus (RSV) vaccines a warning ...

Barré syndrome, although it said data don’t prove a causal link and affirmed the shots’ benefit outweighs their risks.

GSK has gained US FDA breakthrough therapy designation for GSK'227 to treat adults with relapsed or refractory osteosarcoma.

Range Financial Group LLC acquired a new stake in GSK plc (NYSE:GSK – Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange ...

ShareThe recent wave of delistings from the Nigerian Exchange (NGX) by notable companies such as Flour Mills of Nigeria (FMN) and GlaxoSmithKline (GSK) has sparked conversations among investors, ...